Safety Pharmacology Society (SPS)

Safety Pharmacology satisfies a key requirement in the process of drug development. Safety Pharmacology studies are required to assess the impact of a new chemical entity (NCE) or biotechnology-derived product for human use on vital organ systems before first-in-man drug testing. Safety Pharmacology studies are defined as those studies that investigate the potential undesirable pharmacodynamic effects of a substance on physiological functions in relation to exposure in the therapeutic range and above.

Mission:
The Safety Pharmacology Society is a nonprofit organization that promotes knowledge, development, application, and training in safety pharmacology—a distinct scientific discipline that integrates the best practices of pharmacology, physiology and toxicology.

Vision:
The Society will lead the global safety pharmacology community in the development and safe medical use of biologically active molecular entities. They will achieve this vision by bridging across disciplines to predict, identify, characterize, monitor, and mitigate potentially undesirable pharmacodynamic activities in nonclinical studies and guiding their translation into clinical trials and beyond, to benefit all patients.